Literature DB >> 10385502

Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors.

B Iung1, E Garbarz, P Michaud, S Helou, B Farah, P Berdah, P L Michel, B Cormier, A Vahanian.   

Abstract

BACKGROUND: The optimal use of percutaneous mitral commissurotomy (PMC) in a wide range of patients requires accurate evaluation of late results and identification of their predictors. METHODS AND
RESULTS: Late results of PMC were assessed in 1024 patients whose mean age was 49+/-14 years. Echocardiography showed that 141 patients (14%) had pliable valves and mild subvalvular disease, 569 (55%) had extensive subvalvular disease, and 314 (31%) had calcified valves. A single balloon was used in 26 patients, a double balloon in 390, and the Inoue Balloon in 608. Good immediate results were defined as valve area >/=1.5 cm2 without regurgitation >2/4 (Sellers' grade) and were obtained in 912 patients. Median duration of follow-up was 49 months. The 10-year actuarial rate of good functional results (survival with no cardiovascular death and no need for surgery or repeat dilatation and in New York Heart Association [NYHA] class I or II) was 56+/-4% in the entire population. Follow-up echocardiography was available in 90% of the patients who experienced poor functional results after good immediate results and showed restenosis in 97% of these. In multivariate analysis, the predictors of poor functional results were old age (P=0.0008), unfavorable valve anatomy (P=0.003), high NYHA class (P<0.0001), atrial fibrillation (P<0.0001), low valve area after PMC (P=0.001), high gradient after PMC (P<0.0001), and grade 2 mitral regurgitation after PMC (P=0.04).
CONCLUSIONS: PMC can be performed with good late results in a variety of patient subsets. Prediction of late events is multifactorial. Knowledge of these predictors can improve patient selection and follow-up.

Entities:  

Mesh:

Year:  1999        PMID: 10385502     DOI: 10.1161/01.cir.99.25.3272

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

Review 1.  Balloon valvuloplasty.

Authors:  A Vahanian
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

2.  Contemporary criteria for the selection of patients for percutaneous balloon mitral valvuloplasty.

Authors:  B D Prendergast; T R D Shaw; B Iung; A Vahanian; D B Northridge
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

3.  Current status of percutaneous valvular procedures.

Authors:  Dominique Himbert; Eric Brochet; David Messika-Zeitoun; Alec Vahanian
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-11

Review 4.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

Review 5.  Prevention and treatment of rheumatic heart disease in the developing world.

Authors:  Andrew C Steer; Jonathan R Carapetis
Journal:  Nat Rev Cardiol       Date:  2009-09-15       Impact factor: 32.419

6.  Mitral balloon valvuloplasty during pregnancy:The long term up to 17 years obstetric outcome and childhood development.

Authors:  Gulraze A; Kurdi W; Niaz Fa; Fawzy Me
Journal:  Pak J Med Sci       Date:  2014-01       Impact factor: 1.088

Review 7.  The long-term outcome of balloon valvuloplasty for mitral stenosis.

Authors:  Bernard Iung; Alec Vahanian
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

8.  Patient profile and results of percutaneous transvenous mitral commissurotomy in mitral restenosis following prior percutaneous transvenous mitral commissurotomy vs surgical commissurotomy.

Authors:  Kamal H Sharma; Sharad Jain; Anand Shukla; Shomu Bohora; Bhavesh Roy; Gaurav D Gandhi; A J Ashwal
Journal:  Indian Heart J       Date:  2013-12-22

9.  Mitral Regurgitation After Percutaneous Mitral Valvuloplasty: Insights Into Mechanisms and Impact on Clinical Outcomes.

Authors:  Maria Carmo P Nunes; Robert A Levine; Renato Braulio; Marcelo A Pascoal-Xavier; Sammy Elmariah; Nayana F A Gomes; Juliana R Soares; William A M Esteves; Xin Zeng; Jacob P Dal-Bianco; Livia S A Passos; Luiz G Passaglia; Victor T Ribeiro; Cláudio L Gelape; Paulo H N Costa; Lucas Lodi-Junqueira; Walderez Dutra; Timothy C Tan; Elena Aikawa; Judy Hung
Journal:  JACC Cardiovasc Imaging       Date:  2020-09-16

10.  A differentiated morphological parameter-coding system to describe the suitability of mitral valve stenoses intended for percutaneous valvotomy.

Authors:  Nikola Bogunovic; Dieter Horstkotte; Werner Scholtz; Lothar Faber; Lukas Bogunovic; Frank van Buuren
Journal:  Heart Vessels       Date:  2014-06-27       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.